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Single-cycle infections have been used to study the human immunodeficiency virus type 1 (HIV-1) life cycle
in CD4+ T-cell lines that differ in their permissiveness for infection. In single-cycle infections of highly
permissive C8166 cells, 50% of the infectious units escaped being blocked by a monoclonal antibody against the
virus binding site on CD4 (leu3a) within 30 min. In contrast, 50% of the infectious units for three less
permissive cell lines (H9, A3.01, and Jurkat) required 4 h to escape the leu3a block. Entry was also more
efficient in the highly permissive cells, with NL4-3 stocks having three times more infectious units for C8166
cells than for H9, A3.01, or Jurkat cells. Postentry steps up through reverse transcription required -3.5 h in
each of the cell lines. The times lapsing between reverse transcription and the expression of reverse transcripts
ranged from 17 to 25 h in the different cell lines. Virus production per cell was also similar in the different cell
lines (within 1.5-fold of each other). These results indicate that a major determinant of the permissiveness of
growing T cells for HIV-1 is the rate and efficiency of virus entry.
CD4+ cell lines vary in their susceptibility to human
immunodeficiency virus type 1 (HIV-1) infection, with inde-
pendent isolates of HIV-1 displaying characteristic poten-
tials for replication on different cell lines (3, 4, 6, 9, 16). To
gain insight into which step or steps of the virus life cycle
determine these differences, we have analyzed single-cycle
infections of a laboratory strain of HIV-1 (HIV-1 NL4-3) in
four T-cell lines that differ in their permissiveness for infec-
tion. These lines included highly permissive C8166 cells (17)
and less permissive H9 (14), A3.01 (5), and Jurkat (21) cells.
Infections were initiated with HIV-1 NL4-3 which had been
recovered from pNL4-3, a DNA constructed from 5' HIV-
1-NY5 and 3' HIV-1-LAV-1 sequences (1). NL4-3 encodes
all known HIV-1 gene products. Most infections were initi-
ated at a multiplicity of -0.25 C8166-infectious units (IU),
with the spread of progeny virus being restricted by the
addition of inhibitors during the first cycle of infection (see
below).
Virus entry was followed with timed additions of leu3a, a
monoclonal antibody with high affinity (Kd = 4.4 x 10-10)
for the virus-binding site on CD4 (13, 17). Addition of 240 ng
of leu3a per ml 10 min prior to the addition of virus
completely blocked infection in each of the lines. The
addition of leu3a did not affect the growth of the lines.
Reverse transcription was followed by timed additions
of an inhibitor of reverse transcriptase, dideoxycytidine
(ddC). The addition of 2 ,uM ddC to cultures prior to the
addition of virus completely prevented infection while caus-
ing only modest reductions in cell growth (<30% reduc-
tions in cell numbers occurred in treated cultures) (11).
Leu3a was also added to cultures receiving ddC to prevent
syncytium formation. Escape from the leu3a or ddC blocks
was scored by culturing cells for a time sufficient for the
infection to have undergone full expression and then assay-
* Corresponding author.
ing for the percentage of cells expressing HIV-1 by in-
direct immunouorescence (15). For C8166 cells, such assays
were performed .26 h after infection. For the less permis-
sive cell lines, assays were performed .45 h after infec-
tion. In initial experiments, assays were performed at two
times (such as 48 and 72 h after infection) to ensure that
the number of virus-expressing cells had reached plateau
levels.
The time required for expression of a completed reverse
transcript was determined by adding ddC and leu3a during
an empirically determined window of time between the
completion of reverse transcription and the expression of
progeny virus. Aliquots of these cultures were assayed for
virus-expressing cells at regular intervals, beginning 18 to 20
h postinfection. The presence of ddC and leu3a in these
cultures prevented the spread of progeny virus and ensured
analysis of a single-cycle infection.
Interestingly, NL4-3 escaped the leu3a block eight times
more rapidly and three times more efficiently in infections of
the highly permissive C8166 cells than in infections of the
less permissive cells (Fig. 1 and Table 1). Whereas only 30
min were required for 50% of an infection to escape the leu3a
block in C8166 infections, 4 h were required for 50% escape
in the H9, A3.01, and Jurkat cultures. The more rapid escape
from the leu3a block in C8166 cells was also accompanied by
more efficient infection, with stocks infecting about three
times more C8166 than H9, A3.01, or Jurkat cells.
Entry of virus into cells requires virus binding, putative
conformational changes in the viral glycoprotein that expose
the fusion domain, and the fusion of viral and host cell
membranes. We do not know which of these steps deter-
mines the differences in the time course of leu3a escape.
Leu3a is very effective at blocking virus binding to CD4.
Leu3a may also be able to displace virus that has undergone
binding but not penetration. The apparent surface densities
of CD4 on the four cell lines did not correlate with the rate or
efficiency of leu3a escape (Table 1). Thus, differences in the
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FIG. 1. Single-cycle infections of NL4-3 in C8166, H9, A3.01, and Jurkat cells. See text for details. Cells were infected at time zero. The
times of addition of leu3a (40) or leu3a and ddC (0) to cultures and the times at which cultures were assayed for virus expression (A, A) are
shown.
time course of leu3a escape are determined by host cell
parameters other than mere surface density of CD4. These
could involve susceptibility to syncytium formation. C8166
cells are unusually susceptible to NL4-3-induced syncytia,
whereas the less permissive cells are either less susceptible
or resistant.
Each of the infections required about 3.5 h to progress
from the leu3a block past the ddC block. The similar length
of this time period in each of the infections suggests that
penetration, uncoating, and reverse transcription follow
similar tempos in each of the infected cell lines. This 3.5-h
TABLE 1. Single-cycle infection of NL4-3 in growing T cellsa
Time (h) Time (h) Time (h)
Cell line Relative needed for needed for needed forCD4 level entrb reverse
transcriptionc
C8166 0.6 0.5 3.5 (3-4) 17 (16-18)
H9 0.3 4 (3-6) 3.5 (3-4) 22 (20-25)
A3.01 1.0 4 (2-6) 3.5 (3-4) 25 (22-29)
Jurkat 0.1 5 (4-5) 3.5 (3-4) 25 (23-26)
a For details, see the text. Values represent the average number of hours
(range) required for specific steps in the HIV-1 life cycle in three independent
experiments. Relative CD4 levels were determined as described in reference
20.
b Hours needed for 50o of the infectious virus to escape the leu3a block.
Hours between leu3a escape and leu3a plus ddC escape.
d Hours between leu3a plus ddC escape and expression of virus proteins.
period is slightly shorter than would be predicted for the
completion of a 9.7-kb reverse transcript by the polymerases
of avian and murine C-type viruses, which incorporate -30
nucleotides per minute (22). Thus, most of the time between
the escape from the leu3a block and the escape from the ddC
block may have been taken up by reverse transcription, with
both penetration and uncoating requiring relatively little
time. Relatively rapid penetration would be consistent with
the results of studies in which trypsin treatments and fluo-
rescence dequenching have demonstrated 50% entry of
prebound virus in <15 min (10, 12).
The time required for expression of reverse transcripts
exhibited a 1.5-fold difference among the cell lines, with an
average of 22 to 25 h elapsing between the ddC escape and
the appearance of virus-expressing cells in H9, A3.01, and
Jurkat cells and only 17 h elapsing in C8166 cells. The
shorter time required for reverse transcript expression in
C8166 cells could reflect Tax expression in these human
T-cell-lymphotropic virus type I-immortalized cells (7): Tax
could shorten the eclipse phase by activating the expression
of the HIV-1 long terminal repeat (19). The time to expres-
sion did not correlate with short doubling time, as C8166
cells had the longest doubling time of the four cell lines
tested.
The relative levels of NL4-3 production also varied about
1.5-fold among the cell lines. During the 27 to 28 h immedi-
ately following the appearance of virus-expressing cells,
C8166 cells produced -0.3 pg of p24 per infected cell,
C 8166
.5 - 16h
0 a. I I .
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whereas A3.01 and H9 cells produced -0.2 pg of p24 per
infected cell.
These results clearly demonstrate that the rate and effi-
ciency with which HIV-1 escapes the leu3a block are the
major determinants of the relative permissiveness of T cells
for infection. We think this finding will be of general impor-
tance in determining the pathogenicity and tropism of HIV-1
isolates. Kim et al. (8) have reported that the relative tropism
of HIV-1-W13 for H9 and U937 (a monocyte-macrophage
line) correlates with the level of virus binding as measured
by cell-associated RNA at 4 h after infection. Entry playing
a key role in permissiveness is also consistent with transfec-
tion overcoming T-cell restrictions on the replication of a
patient isolate (2).
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